JPWO2022015922A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022015922A5 JPWO2022015922A5 JP2023503124A JP2023503124A JPWO2022015922A5 JP WO2022015922 A5 JPWO2022015922 A5 JP WO2022015922A5 JP 2023503124 A JP2023503124 A JP 2023503124A JP 2023503124 A JP2023503124 A JP 2023503124A JP WO2022015922 A5 JPWO2022015922 A5 JP WO2022015922A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- trp
- phe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063052502P | 2020-07-16 | 2020-07-16 | |
| US63/052,502 | 2020-07-16 | ||
| PCT/US2021/041737 WO2022015922A1 (en) | 2020-07-16 | 2021-07-15 | Hla class ii-restricted drb t cell receptors against ras with g12v mutation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023535366A JP2023535366A (ja) | 2023-08-17 |
| JPWO2022015922A5 true JPWO2022015922A5 (enExample) | 2024-07-18 |
Family
ID=77265247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023503124A Pending JP2023535366A (ja) | 2020-07-16 | 2021-07-15 | Ｇ１２ｖ変異を有するｒａｓに対するｈｌａクラスｉｉ拘束性ｄｒｂ ｔ細胞受容体 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230257440A1 (enExample) |
| EP (1) | EP4182029A1 (enExample) |
| JP (1) | JP2023535366A (enExample) |
| KR (1) | KR20230046294A (enExample) |
| CN (1) | CN116348484A (enExample) |
| AU (1) | AU2021309958A1 (enExample) |
| CA (1) | CA3185483A1 (enExample) |
| WO (1) | WO2022015922A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3209741A1 (en) | 2021-02-26 | 2022-09-01 | Shohei Koide | Compositions and methods comprising antibodies that bind to covalent peptide conjugates |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1545204T3 (en) | 2002-09-06 | 2016-11-14 | The Government Of The Us Secretary Dept Of Health And Human Services | Immunotherapy with in vitro selected antigen-specific lymphocytes following non-myeloablative lymphodepletive chemotherapy |
| US8383099B2 (en) | 2009-08-28 | 2013-02-26 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Adoptive cell therapy with young T cells |
| EP2618835B1 (en) * | 2010-09-20 | 2017-07-05 | BioNTech Cell & Gene Therapies GmbH | Antigen-specific t cell receptors and t cell epitopes |
| US20120244133A1 (en) | 2011-03-22 | 2012-09-27 | The United States of America, as represented by the Secretary, Department of Health and | Methods of growing tumor infiltrating lymphocytes in gas-permeable containers |
| PL3223850T3 (pl) * | 2014-11-26 | 2020-08-24 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Receptory limfocytów t przeciwko zmutowanemu kras |
| EP3901169A1 (en) * | 2015-09-15 | 2021-10-27 | The United States of America, as represented by the Secretary, Department of Health and Human Services | T cell receptors recognizing hla-cw8 restricted mutated kras |
| SG11202002425PA (en) * | 2017-09-20 | 2020-04-29 | The United States Of America As Represented By The Secretary | Hla class ii-restricted t cell receptors against mutated ras |
| CN111836638B (zh) * | 2017-12-04 | 2024-10-29 | 美国卫生和人力服务部 | 针对突变的ras的hla i类限制性t细胞受体 |
| WO2019157279A1 (en) * | 2018-02-10 | 2019-08-15 | Berkeley Lights, Inc. | Mutant idh1 specific t cell receptor |
-
2021
- 2021-07-15 EP EP21752355.4A patent/EP4182029A1/en active Pending
- 2021-07-15 CN CN202180050745.7A patent/CN116348484A/zh active Pending
- 2021-07-15 JP JP2023503124A patent/JP2023535366A/ja active Pending
- 2021-07-15 AU AU2021309958A patent/AU2021309958A1/en active Pending
- 2021-07-15 KR KR1020237005176A patent/KR20230046294A/ko active Pending
- 2021-07-15 CA CA3185483A patent/CA3185483A1/en active Pending
- 2021-07-15 US US18/015,781 patent/US20230257440A1/en active Pending
- 2021-07-15 WO PCT/US2021/041737 patent/WO2022015922A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Boyson et al. | Identification of a novel MHC class I gene, Mamu-AG, expressed in the placenta of a primate with an inactivated G locus. | |
| JP7256794B2 (ja) | 変異型ｒａｓに対するｈｌａクラスｉｉ拘束性ｔ細胞受容体 | |
| JP2021505136A5 (enExample) | ||
| RU2752528C2 (ru) | Композиции и библиотеки, содержащие рекомбинантные полинуклеотиды, кодирующие Т-клеточные рецепторы, и способы применения рекомбинантных Т-клеточных рецепторов | |
| KR20230079259A (ko) | Kras 돌연변이 특이적 t세포 수용체의 스크리닝 및 항종양 용도 | |
| Elliott | Transporter associated with antigen processing | |
| GB2609760A (en) | HLA Class I-restricted T cell receptors against RAS with G12D mutation | |
| JP2020534828A5 (enExample) | ||
| CN111032686B (zh) | 血液恶性肿瘤的治疗 | |
| JPH08109199A (ja) | Ｔ細胞抗原受容体に対する抗体 | |
| Fellah et al. | Conserved structure of amphibian T-cell antigen receptor beta chain. | |
| JP7742354B2 (ja) | Ｇ１２ｖ変異を有するｒａｓに対するｈｌａクラスｉｉ拘束性ｔ細胞受容体 | |
| CN113621048A (zh) | T细胞抗原受体、其多聚体复合物及其制备方法和应用 | |
| CN120607607A (zh) | 针对含有g12r突变的ras的hla第ii类限制性t细胞受体 | |
| JP2023534241A (ja) | Ｇ１２ｄ変異を有するｒａｓに対するｈｌａクラスｉｉ拘束性ｄｒｂ ｔ細胞受容体 | |
| JPWO2022015922A5 (enExample) | ||
| JPWO2020154275A5 (enExample) | ||
| JPWO2022015694A5 (enExample) | ||
| US8658177B2 (en) | Promiscuous HER-2/Neu CD4 T cell epitopes | |
| JP2023535366A (ja) | Ｇ１２ｖ変異を有するｒａｓに対するｈｌａクラスｉｉ拘束性ｄｒｂ ｔ細胞受容体 | |
| GB2614166A (en) | T cell receptors recognizing R273C or Y220C mutations in P53 | |
| RU2849866C1 (ru) | T-клеточные рецепторы, рестриктированные по hla класса i, против ras с мутацией g12d | |
| Hayball et al. | The immune function of MHC class II molecules mutated in the putative superdimer interface | |
| JPWO2022051449A5 (enExample) | ||
| NZ805541A (en) | Hla class i-restricted t cell receptors against mutated ras |